Bristol-Myers Squibb
BMY
BMY
2,214 hedge funds and large institutions have $71.1B invested in Bristol-Myers Squibb in 2025 Q3 according to their latest regulatory filings, with 157 funds opening new positions, 808 increasing their positions, 970 reducing their positions, and 147 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
2.96% less ownership
Funds ownership: 80.45% → 77.49% (-3%)
6% less capital invested
Capital invested by funds: $75.8B → $71.1B (-$4.65B)
17% less repeat investments, than reductions
Existing positions increased: 808 | Existing positions reduced: 970
Holders
2,214
Holding in Top 10
19
Calls
$1.39B
Puts
$1.44B
Top Buyers
| 1 | +$268M | |
| 2 | +$238M | |
| 3 | +$207M | |
| 4 |
Two Sigma Advisers
New York
|
+$163M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$159M |
Top Sellers
| 1 | -$1.52B | |
| 2 | -$802M | |
| 3 | -$391M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$267M |
| 5 |
Bank of New York Mellon
New York
|
-$190M |